Impetus Digital

MARCH 15, 2024

Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). There are currently more than 2,000 oncology products under development.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

Pharmaceutical Technology

JUNE 29, 2022

Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market. That is a key competitive advantage,” says Laursen. “We Developing best-in-class speciality enzymes.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

Clarivate

OCTOBER 25, 2021

This year, Clarivate acquired Bioinfogate , a leading provider of analytics solutions in the life sciences and producer of the OFF-X portal. OFF-X is already integrated with several Cortellis products, including Cortellis Drug Discovery Intelligence and Cortellis Competitive Intelligence.

Safety 110

Safety Biopharma Competition Management 110

PM360

APRIL 22, 2024

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.

Education 59

Education Physicians Healthcare Healthcare 59

The Marketing Advantage

MARCH 9, 2021

However, in the complex pharma, biotech and medical device landscape, the easy way of targeting HCPs is, unfortunately, not the right way in most circumstances, and ultimately diminishes sales and adoption. This strategy will maximize sales and lead to faster adoption.

Sales 52

Sales Competition Marketing Biopharma 52

European Pharmaceutical Review

DECEMBER 19, 2022

1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.

Medicine 52

Medicine Biopharma Safety Food 52

Clarivate

JULY 31, 2023

The migration of these products and services into the Clarivate portfolio further bolster solutions that support pharmacovigilance medical literature monitoring, patent research, systematic review literature searches, MDR literature review searches, as well as competitive and business intelligence research.

Healthcare 52

Healthcare Healthcare Safety Competition 52

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Clarivate

OCTOBER 25, 2023

exclusions exist for orphan drug designation and biosimilar competition ). This post was written by Roy Moore, Senior Healthcare Research and Data Analyst, and Bill Melville, Lead Healthcare Research and Data Analyst The post Five points on CMS’s first ten picks for price negotiations appeared first on Clarivate.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

European Pharmaceutical Review

NOVEMBER 30, 2023

For example, the GMP report stated that the contract development and manufacturing organisation (CDMO) eXmoor pharma, will be launching a cell and gene therapy process development and clinical manufacturing facility in Bristol. Licensing of the manufacturing suites is expected in early 2024.

Manufacturing 71

Manufacturing Recruitment Medicine Biopharma 71

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

PM360

SEPTEMBER 28, 2022

At Roche at the time, his job was to lead a task force which was given the objective of planning a strategy to preserve and protect the companies billion-dollar originator biologics franchises as well as build a plan which would counter the introduction and use of biosimilars. Now, as the President of Accord BioPharma , the U.S.

Competition 98

Competition Marketing Biopharma Manufacturing 98

Clarivate

APRIL 18, 2024

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. As a lead healthcare research and data analyst, she analyses the Texas and Georgia healthcare markets and tracks the rapidly evolving convenient care industry.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 10, 2022

Fruquintinib will face fierce competition should it be approved in the third- and later-line setting. The question of which KRAS inhibitor is most effective remains elusive, although being first to market in addition to strong efficacy and safety data could differentiate the more competitive agent.

Marketing 52

Marketing Safety Patients Competition 52

Pharmaceutical Technology

MARCH 24, 2023

GC Biopharma is also running a Phase III trial for its live-attenuated vaccine GC-3107A to replace BCG. Poverty and overcrowding, key factors leading to TB spreads, are challenging to tackle on a global level. “If According to GlobalData, there are six TB vaccines in Phase III clinical trials right now.

Pharma 64

Pharma Side effects Marketing Biopharma 64

Pharmaceutical Technology

JANUARY 25, 2023

In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp. In such times, experts expect partnerships between biotechs and big pharma, like the Anima Biotech/AbbVie deal announced earlier this month , to become even more popular.

Marketing 69

Marketing Biopharma Pharma Competition 69